Skip to main content
SpringerLink
Log in

Active surveillance preferred option in low-risk prostate cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Benard A, et al. Cost-utility analysis of focal HIFU versus active surveillance for low- to intermediate-risk prostate cancer using a Markov multi-state Model. BJU International : 12 Jul 2019. Available from: URL: http://doi.org/10.1111/bju.14867

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Active surveillance preferred option in low-risk prostate cancer. PharmacoEcon Outcomes News 833, 4 (2019). https://doi.org/10.1007/s40274-019-6068-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6068-2

Search

Navigation